Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir.
Shim JS; Rao R; Beebe K; Neckers L; Han I; Nahta R; Liu JO; Journal Of The National Cancer Institute, 2012, vol. 104, issue 20, p 1576, ISSN 14602105. ISBN 14602105.
Full Text Resources Located for this Citation